Engineering iPSCs with Synthetic Receptors to Drive Differentiation Compatible with Scale-Up

Time: 12:00 pm
day: Day Two


  • By genetically engineering iPSCs to express a synthetic cytokine receptor, iPSCs can more efficiently be differentiated into functional, persistent immune cell types
  • Differentiation can be performed in suspension, making it compatible with efficient scale-up production
  • This overall approach may be used in a manufacturing setting to drive high purity immune cell production